Alpha Omega Wealth Management’s LeMaitre Vascular LMAT Stock Holding History

Alpha Omega Wealth Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-23	Closed	-$1K	–	411
2019 Q2	$1K	Hold	23	–	–	﹤0.01%	604
2019 Q1	$1K	Buy	+23	New	+$614	﹤0.01%	554

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Alpha Omega Wealth Management's LMAT Position: Q3 2019 in Review

Alpha Omega Wealth Management sold out of LeMaitre Vascular (LMAT) in Q3 2019, closing a stake of 23 shares — an estimated $1K sold.

Alpha Omega Wealth Management first reported a position in LMAT in Q1 2019 and held it in 2 quarters. The position peaked at $1K in Q2 2019. 145 funds tracked by Wall St. Rank hold LMAT as of Q3 2019.

Alpha Omega Wealth Management reported no remaining LeMaitre Vascular position as of Q3 2019 after selling out during the quarter.
Alpha Omega Wealth Management sold 23 LeMaitre Vascular shares in Q3 2019, an estimated $1K.
Alpha Omega Wealth Management first reported a position in LeMaitre Vascular in Q1 2019 and held it in 2 quarters.
Alpha Omega Wealth Management's LeMaitre Vascular position peaked at $1K in Q2 2019.
145 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2019.

Based on Alpha Omega Wealth Management's 13F filing for Q3 2019, filed 12 Nov 2019.